← Back to Search

One-time Trifold Brochure titled "HIV: 50 Years or Older" for HIV/AIDS (CHAMP Trial)

N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
50 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly
Awards & highlights

CHAMP Trial Summary

This trial will study the feasibility and acceptability of a cognitive behavioral therapy (CBT) intervention designed to help improve the psychological and physical health of older people with HIV. The 12-week program will teach participants stress-management and health-promoting behaviors.

Who is the study for?
This trial is for people over 50 who are HIV positive, have had an undetectable viral load in the past year, and are on effective antiretroviral therapy (ART). Participants must be fluent in English, psychiatrically stable, and able to give informed consent. Those under 50, not on ART or unable to provide recent health records confirming their HIV status cannot join.Check my eligibility
What is being tested?
The study tests a CBT-based group intervention designed for older individuals with HIV. It aims to improve psychological and physical well-being by teaching skills to manage stress related to HIV and aging. The program includes weekly sessions over 12 weeks plus educational material provided through a brochure.See study design
What are the potential side effects?
Since this is a behavioral intervention focusing on education and skill development rather than medication or medical procedures, traditional side effects associated with drugs are not expected. However, participants may experience emotional discomfort discussing personal issues during sessions.

CHAMP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 50 years old or older.

CHAMP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-week follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-week follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Acceptability of the CBT group intervention
Changes in psychological distress
Feasibility of the CBT group intervention
+1 more

CHAMP Trial Design

2Treatment groups
Experimental Treatment
Group I: Information-only GroupExperimental Treatment1 Intervention
Participants in the control group will receive a one-time trifold brochure titled "HIV: 50 Years or Older."
Group II: CBT GroupExperimental Treatment1 Intervention
This 12-week intervention program leverages evidence-based traditional and contemporary CBT strategies, with the goal of improving the psychological and physical functioning of older people with HIV by providing education and support to learn strategies to: a.) better manage stressors associated with HIV and aging (e.g., treatment access and engagement, and multi-morbidity), and b.) increase health-promoting behaviors (e.g., physical activity).

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,305 Total Patients Enrolled

Media Library

CBT-Based Group Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05434741 — N/A
HIV/AIDS Research Study Groups: CBT Group, Information-only Group
HIV/AIDS Clinical Trial 2023: CBT-Based Group Intervention Highlights & Side Effects. Trial Name: NCT05434741 — N/A
CBT-Based Group Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05434741 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must participants meet to qualify for this research?

"This clinical trial seeks 50 participants aged between the half-century mark and a century of life. To qualify, these individuals must have tested HIV+ within the past year; provide either paper or digital evidence to that effect, be actively engaging in ART (with associated medical records); possess English fluency both verbally and literately; give informed consent for participation, and demonstrate mental stability as judged by clinicians."

Answered by AI

How many individuals have been inducted into this trial thus far?

"Affirmative. In accordance with the data posted on clinicaltrials.gov, this medical investigation is still in search of participants and was first announced on June 20th 2022. The trial needs to find 50 patients across 1 site before it can conclude its research."

Answered by AI

Is this medical experiment still open to new participants?

"Affirmative, clinicaltrials.gov reveals that this investigation is presently enrolling participants. It was first made available on June 20th 2022 and has been modified as recently as September 1st 2022. 50 volunteers are sought from a single medical centre."

Answered by AI

Does this medical trial cater to individuals aged 85 or above?

"In accordance with the guidelines for this medical trial, applicants must be at least 50 years old and not exceed 100."

Answered by AI
~18 spots leftby Apr 2025